Chitosan modified halloysite nanotubes as emerging porous microspheres for drug carrier
Source abstract
Abstract
Abstract Natural halloysite (Hal) nanotubes were well dispersed and thoroughly emulsified to prepare the porous microspheres Hal-chitosan (Hal-CTS) in a water/oil microemulsion, which was further loaded with aspirin (Asp) as a model drug to investigate the drug release behavior. The charge-mediated adsorption of molecules to the surface of Hal could facilitate the dispersion of Hal in aqueous media and enabled Hal to assemble into microspheres. The microspheres had interconnected pores, large pore volume, high specific surface area and hierarchical pore distribution, which was beneficial to the entrance of Asp molecules. The porous microspheres showed excellent loading capacity for Asp as high as 42.4 wt%, around 20 times higher than the pristine Hal (2.1 wt%). The release results indicated that Hal-CTS/Asp nanocomposites had the lower release in the simulated gastric fluid, whereas more rapid release rate and higher release amount in the simulated intestinal fluid, which could help to maintain effective concentration of Asp in the body and reduce the maximum extent of the side effects to the stomach. The as-prepared Hal-CTS/Asp nanocomposites could have potential application in the drug carrier systems due to their natural and excellent biocompatibility.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Clay minerals and soil interactions · Therapeutic Uses of Natural Elements · Iron oxide chemistry and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (49)
Show source-provided references
1. Halloysite clay nanotubes as a ceramic “skeleton” for functional biopolymer composites with sustained drug release10.1039/c3tb20059k ↗
2. Folic acid modified clay/polymer nanocomposites for selective cell adhesion10.1039/C4TB00850B ↗
3. In search of pure liquid salt forms of aspirin: ionic liquid approaches with acetylsalicylic acid and salicylic acid10.1039/b923855g ↗
4. Interactions of DNA with clay minerals and soil colloidal particles and protection against degradation by dnase10.1021/es0522985 ↗
5. Natural nanotube-based biomimetic porous microspheres for significantly enhanced biomolecule immobilization10.1021/sc400199v ↗
6. Highly-controllable imprinted polymer nanoshell at the surface of magnetic halloysite nanotubes for selective recognition and rapid adsorption of tetracycline10.1039/c3ra45779f ↗
7. Aspirin loading and release from MCM-41 functionalized with aminopropyl groups via Co-condensation or postsynthesis modification methods10.1021/jp3063959 ↗
8. An experimental and computational study of the loading and release of aspirin from zeolite HY10.1021/jp3067266 ↗
9. In situ generation of sodium alginate/hydroxyapatite/halloysite nanotubes nanocomposite hydrogel beads as drug-controlled release matrices10.1039/c3tb20971g ↗
10. A ceramic drug delivery vehicle for oral administration of highly potent opioids10.1002/jps.21814 ↗
11. Fluorescence and room temperature activity of Y2O3:(Eu3+,Au3+)/palygorskite nanocomposite10.1039/C4DT01628A ↗
12. Synthesis and magnetic property of SiO2 coated Fe3O4/palygorskite10.1142/S1793604715500563 ↗
13. Carbon hybridized halloysite nanotubes for high-performance hydrogen storage capacities10.1038/srep12429 ↗
14. Composite microparticles of halloysite clay nanotubes bound by calcium carbonate10.1016/j.jcis.2015.12.031 ↗
15. Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems10.1039/C5CS00798D ↗
16. Cellular interactions of doxorubicin-loaded DNA-modified halloysite nanotubes10.1039/c3nr02665e ↗
17. Heterogeneous modification of chitosan via nitroxide-mediated polymerization10.1039/C2PY20544K ↗
18. Kaolinite stabilized paraffin composite phase change materials for thermal energy storage10.1016/j.clay.2015.07.033 ↗
19. Morphology-controllable Li2SiO3 nanostructures10.1039/C4CE00297K ↗
20. Pd hybridizing ZnO/kaolinite nanocomposites: synthesis, microstructure, and enhanced photocatalytic property10.1016/j.clay.2014.05.007 ↗
21. Soybean whey protein/chitosan complex behavior and selective recovery of kunitz trypsin inhibitor10.1021/jf501904g ↗
22. Microwave-assisted synthesis and interfacial features of CdS/kaolinite nanocomposite10.1016/j.colsurfa.2013.10.054 ↗
23. Assembling strategy to synthesize palladium modified kaolin nanocomposites with different morphologies10.1038/srep13763 ↗
24. Composite of coal-series kaolinite and capric–lauric acid as form-stable phase-change material10.1002/ente.201402125 ↗
25. Fabrication and conductive performance of antimony-doped tin oxide-coated halloysite nanotubes10.1142/S1793292015500782 ↗
26. Natural halloysite nanotubes modified as an aspirin carrier10.1039/C4RA09006C ↗
27. Preparation and characterization of silane coupling agent modified halloysite for Cr(VI) removal10.1021/ie200951n ↗
28. Liquid crystalline phase behavior and fiber spinning of cellulose/ionic liquid/halloysite nanotubes dispersions10.1039/c4ta00225c ↗
29. Halloysite clay nanotubes for controlled release of protective agents10.1021/nn800259q ↗
30. Functionalized-chitosan/quantum dot nano-hybrids for nanomedicine applications: towards biolabeling and biosorbing phosphate metabolites10.1039/c3tb00498h ↗
31. Multicavity halloysite-amphiphilic cyclodextrin hybrids for co-delivery of natural drugs into thyroid cancer cells10.1039/C5TB00564G ↗
32. Functionalized halloysite multivalent glycocluster as a new drug delivery system10.1039/C4TB01272K ↗
33. Emerging parallel dual two-dimensional composites: natural clay mineral hybridizing MoS2 and interfacial structure10.1002/adfm.201504942 ↗
34. Perovskite LaFeO3/montmorillonite nanocomposites: synthesis, interface characteristics and enhanced photocatalytic activity10.1038/srep19723 ↗
35. Acid-hybridized expanded perlite as a composite phase-change material in wallboard10.1039/C5RA10173E ↗
36. Electrospun poly(lactic-co-glycolic acid)/halloysite nanotube composite nanofibers for drug encapsulation and sustained release10.1039/c0jm01328e ↗
37. Development of noncytotoxic chitosan–gold nanocomposites as efficient antibacterial materials10.1021/am508094e ↗
38. Intestinal permeability of oxytetracycline from chitosan-montmorillonite nanocomposites10.1016/j.colsurfb.2013.11.009 ↗
39. Methoxy-modified kaolinite as a novel carrier for high-capacity loading and controlled-release of the herbicide amitrole10.1038/srep08870 ↗
40. Loading and in vitro release of ibuprofen in tubular halloysite10.1016/j.clay.2014.01.018 ↗
41. Spray-dried magnetic chitosan/Fe3O4/halloysite nanotubes/ofloxacin microspheres for sustained release of ofloxacin10.1039/c3ra43874k ↗
42. Synthesis of nanoporous materials Al-MCM-41 from natural halloysite10.1142/S1793292015500058 ↗
43. Electrospun microfiber membranes embedded with drug-loaded clay nanotubes for sustained antimicrobial protection10.1021/nn506255e ↗
44. Selective modification of halloysite lumen with octadecylphosphonic acid: new inorganic tubular micelle10.1021/ja210258y ↗
45. Biomimetic dopamine derivative for selective polymer modification of halloysite nanotube lumen10.1021/ja303340f ↗
46. Well-dispersed chitosan/graphene oxide nanocomposites10.1021/am100222m ↗
47. Functionalization of halloysite clay nanotubes by grafting with γ-aminopropyltriethoxysilane10.1021/jp805657t ↗
48. Properties and applications of halloysite nanotubes: recent research advances and future prospects10.1016/j.clay.2015.05.001 ↗
49. Applications and interfaces of halloysite nanocomposites10.1016/j.clay.2015.06.034 ↗